Cover Image
Market Research Report

Indonesia Pharmaceuticals & Healthcare Q2 2020

Published by Fitch Solutions, Inc. Product code 177846
Published Content info 87 Pages
Delivery time: 1-2 business days
Back to Top
Indonesia Pharmaceuticals & Healthcare Q2 2020
Published: February 25, 2020 Content info: 87 Pages

Key View:

Having established itself as a key pharmaceutical market in South East Asia, Indonesia is already a host to many

multinationals and domestic drugmakers. Authorities are also investing in regulatory improvement initiatives, which will

complement their efforts to achieve universal healthcare coverage. However, some foreign players may remain wary of committing

to the market due to the prevalence of counterfeit medicines, low per capital purchasing power and the uncertain funding base.

Table of Contents
Product Code: SSID03_20200401

Table of Contents

  • Key View
  • SWOT
  • Industry Forecast
  • Pharmaceutical Market Forecast
  • Healthcare Market Forecast
  • Prescription Drug Market Forecast
  • Patented Drug Market Forecast
  • Generic Drug Market Forecast
  • OTC Medicine Market Forecast
  • Pharmaceutical Trade Forecast
  • Industry Risk/Reward Index
  • Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
  • Innovative Pharmaceuticals Risk/Reward Index
  • Regulatory Development
  • Regulatory Review
  • Market Overview

Competitive Landscape

  • Company Profile
  • Bayer
  • Darya-Varia Group
  • GlaxoSmithKline
  • Indofarma
  • Kimia Farma
  • MSD
  • Merck Group
  • Novartis
  • Pfizer
  • PT Bio Farma
  • PT Kalbe Farma
  • Sanofi
  • Soho Global Healthcare Group
  • Indonesia Demographic Outlook
  • Pharmaceuticals & Healthcare Glossary
  • Pharmaceuticals & Healthcare Methodology
Back to Top